The nation of Zimbabwe has declined a substantial US health deal valued at $367m (272 million pounds) over five years over the United States' demand for sensitive biological samples.
This move came to light after a official document dated December was leaked, revealing that Head of State Emmerson Mnangagwa believed the agreement was "lopsided".
A government representative later clarified that the United States was demanding access to health data for research and commercial gain but refused to share the benefits from any future vaccines.
"We must now begin the difficult and regrettable process of ending our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for continued talks to find a agreement suitable to all parties so the nation's vital HIV treatment initiative can continue.
Broader Context
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a court halted a similar deal with the US after concerns were filed about the security of citizens' health data.
Since resuming the presidency last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had administered aid for the American government, but Trump argued its expenditure was "wasteful" and his government was seeking direct bilateral deals to enhance transparency and accountability.
Based on statements, 16 nations in Africa have to date signed these new agreements, constituting over $18.3bn in committed funds.
Details of the Declined Deal
The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership might have yielded extraordinary advantages for Zimbabwean communities, especially the 1.2 million presently receiving HIV treatment via US-supported initiatives," Tremont added.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".
"Our nation was requested to provide its biological resources and data indefinitely, with no equivalent promise of benefiting from any medical innovations – like new medicines or tests – that could be developed from that shared data," Mangwana explained.
"In essence, our nation would supply the basic resources for scientific discovery without any certainty that the resulting innovations would be accessible to our population if a future health crisis arise."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were upending systems previously established via the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to manage potential global health emergencies.
"This mechanism is intended to guarantee that when a nation contributes its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to develop them."
These objections over the US deal "are not meant as opposition to America," he added.
"We welcome further dialogue with our US partners on how subsequent collaboration could be arranged in a manner that honours the sovereignty and interests of each country."
Medical Community Reaction
A leading public health body said it recognised the government's concerns, but urged that talks should continue since a large portion of the country's HIV programmes relied on external financing.
"If technical issues arise, such as those relating to information security or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," it commented.
This impasse highlights the continuing debate between accepting crucial international aid and safeguarding a country's data in an ever more interconnected world.